-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Interpace Biosciences, Inc. annual/quarterly Depreciation, Depletion and Amortization history and growth rate from 2010 to 2023.
- Interpace Biosciences, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2023 was $356K, a 54.4% decline year-over-year.
- Interpace Biosciences, Inc. annual Depreciation, Depletion and Amortization for 2023 was $1.03M, a 59.9% decline from 2022.
- Interpace Biosciences, Inc. annual Depreciation, Depletion and Amortization for 2022 was $2.56M, a 52.4% decline from 2021.
- Interpace Biosciences, Inc. annual Depreciation, Depletion and Amortization for 2021 was $5.37M, a 2.31% decline from 2020.
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)